LONDON (Reuters) - Novartis drug Afinitor, expected to be a big seller for the Swiss group, has been rejected by Britain's health cost agency NICE due to uncertainty over its survival benefits in breast cancer. Novartis said it was "extre...
Source: http://health.yahoo.net/news/s/nm/uk-cost-body-rejects-novartis-breast-cancer-drug
source here i found it found it for you found it
No comments:
Post a Comment
Note: only a member of this blog may post a comment.